Pub Date : 2022-11-01Epub Date: 2022-05-20DOI: 10.1007/s43441-022-00410-3
Morenike Oluwatoyin Folayan, Magda Conway, Carolyn Russo, Nilza Diniz, Lungile P Jafta, Nadia A Sam-Agudu, Sarah Bernays, Victor M Santana, Carla Epps, Mark A Turner
The concept of health equity-the attainment of the highest possible level of health for all members of society-requires equitable access to all aspects of healthcare, including pediatric drug development. However, many communities are under-represented in pediatric drug development programs. Barriers to participation include geographic, economic, racial/ethnic bias, legal, cultural, linguistic, and other factors. While there is no "one size fits all" approach to addressing these barriers, community engagement and collaboration is recognized by the Centers for Disease Control, the World Health Organization, and other global health organizations as a cornerstone for building a more equitable healthcare system. In this article, we will present case studies of stakeholder and community engagement in clinical research for rare diseases and other areas of healthcare, as examples of strategies and practices for actively involving under-represented communities and fostering their participation in pediatric drug development programs. These studies may serve as templates for facilitating equity in pediatric drug development from aspiration into operation.
{"title":"Health Equity in Pediatric Drug Development: Translating Aspiration into Operation.","authors":"Morenike Oluwatoyin Folayan, Magda Conway, Carolyn Russo, Nilza Diniz, Lungile P Jafta, Nadia A Sam-Agudu, Sarah Bernays, Victor M Santana, Carla Epps, Mark A Turner","doi":"10.1007/s43441-022-00410-3","DOIUrl":"10.1007/s43441-022-00410-3","url":null,"abstract":"<p><p>The concept of health equity-the attainment of the highest possible level of health for all members of society-requires equitable access to all aspects of healthcare, including pediatric drug development. However, many communities are under-represented in pediatric drug development programs. Barriers to participation include geographic, economic, racial/ethnic bias, legal, cultural, linguistic, and other factors. While there is no \"one size fits all\" approach to addressing these barriers, community engagement and collaboration is recognized by the Centers for Disease Control, the World Health Organization, and other global health organizations as a cornerstone for building a more equitable healthcare system. In this article, we will present case studies of stakeholder and community engagement in clinical research for rare diseases and other areas of healthcare, as examples of strategies and practices for actively involving under-represented communities and fostering their participation in pediatric drug development programs. These studies may serve as templates for facilitating equity in pediatric drug development from aspiration into operation.</p>","PeriodicalId":55579,"journal":{"name":"Archiv Fur Dermatologie Und Syphilis","volume":"158 1","pages":"991-1003"},"PeriodicalIF":2.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122543/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73139085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-04-01Epub Date: 2016-10-18DOI: 10.1007/s00262-016-1917-3
Peter L Stern, Richard Harrop
The natural history of a patient's cancer is often characterised by genetic diversity and sequential sweeps of clonal dominance. It is therefore not surprising that identifying the most appropriate tumour-associated antigen for targeted intervention is challenging. The 5T4 oncofoetal antigen was identified by searching for surface molecules shared between human trophoblast and cancer cells with the rationale that they may function to allow survival of the foetus as a semi-allograft in the mother or a tumour in its host. The 5T4 protein is expressed by many different cancers but rarely in normal adult tissues. 5T4 molecules are 72 kD, heavily N-glycosylated proteins with several leucine-rich repeats which are often associated with protein-protein interactions. 5T4 expression is associated with the directional movement of cells through epithelial mesenchymal transition, potentiation of CXCL12/CXCR4 chemotaxis and inhibition of canonical Wnt/beta-catenin while favouring non-canonical pathway signalling; all processes which help drive the spread of cancer cells. The selective pattern of 5T4 tumour expression, association with a tumour-initiating phenotype plus a mechanistic involvement with cancer spread have underwritten the clinical development of different immunotherapeutic strategies including a vaccine, a tumour-targeted superantigen and an antibody drug conjugate. In addition, a chimeric antigen receptor T cell approach targeting 5T4 expressing tumour cells is in pre-clinical development. A key challenge will include how best to combine each 5T4 targeted immunotherapy with the most appropriate standard of care treatment (or adjunct therapy) to maximise the recovery of immune control and ultimately eliminate the tumour.
{"title":"5T4 oncofoetal antigen: an attractive target for immune intervention in cancer.","authors":"Peter L Stern, Richard Harrop","doi":"10.1007/s00262-016-1917-3","DOIUrl":"10.1007/s00262-016-1917-3","url":null,"abstract":"<p><p>The natural history of a patient's cancer is often characterised by genetic diversity and sequential sweeps of clonal dominance. It is therefore not surprising that identifying the most appropriate tumour-associated antigen for targeted intervention is challenging. The 5T4 oncofoetal antigen was identified by searching for surface molecules shared between human trophoblast and cancer cells with the rationale that they may function to allow survival of the foetus as a semi-allograft in the mother or a tumour in its host. The 5T4 protein is expressed by many different cancers but rarely in normal adult tissues. 5T4 molecules are 72 kD, heavily N-glycosylated proteins with several leucine-rich repeats which are often associated with protein-protein interactions. 5T4 expression is associated with the directional movement of cells through epithelial mesenchymal transition, potentiation of CXCL12/CXCR4 chemotaxis and inhibition of canonical Wnt/beta-catenin while favouring non-canonical pathway signalling; all processes which help drive the spread of cancer cells. The selective pattern of 5T4 tumour expression, association with a tumour-initiating phenotype plus a mechanistic involvement with cancer spread have underwritten the clinical development of different immunotherapeutic strategies including a vaccine, a tumour-targeted superantigen and an antibody drug conjugate. In addition, a chimeric antigen receptor T cell approach targeting 5T4 expressing tumour cells is in pre-clinical development. A key challenge will include how best to combine each 5T4 targeted immunotherapy with the most appropriate standard of care treatment (or adjunct therapy) to maximise the recovery of immune control and ultimately eliminate the tumour.</p>","PeriodicalId":55579,"journal":{"name":"Archiv Fur Dermatologie Und Syphilis","volume":"117 1","pages":"415-426"},"PeriodicalIF":5.8,"publicationDate":"2017-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11029567/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73120519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2016-06-01Epub Date: 2015-11-02DOI: 10.1007/s11084-015-9470-1
Annette Brandt, Eva Posthoff, Jean-Pierre de Vera, Silvano Onofri, Sieglinde Ott
The lichen Xanthoria elegans has been exposed to space and simulated Mars-analogue environment in the Lichen and Fungi Experiment (LIFE) on the EXPOSE-E facility at the International Space Station (ISS). This long-term exposure of 559 days tested the ability of various organisms to cope with either low earth orbit (LEO) or Mars-analogue conditions, such as vacuum, Mars-analogue atmosphere, rapid temperature cycling, cosmic radiation of up to 215 ± 16 mGy, and insolation of accumulated doses up to 4.87 GJm(-2), including up to 0.314 GJm(-2) of UV irradiation. In a previous study, X. elegans demonstrated considerable resistance towards these conditions by means of photosynthetic activity as well as by post-exposure metabolic activity of 50-80% in the algal and 60-90% in the fungal symbiont (Brandt et al. Int J Astrobiol 14(3):411-425, 2015). The two objectives of the present study were complementary: First, to verify the high post-exposure viability by using a qualitative cultivation assay. Second, to characterise the cellular damages by transmission electron microscopy (TEM) which were caused by the space and Mars-analogue exposure conditions of LIFE. Since the algal symbiont of lichens is considered as the more susceptible partner (de Vera and Ott 2010), the analyses focused on the photobiont. The study demonstrated growth and proliferation of the isolated photobiont after all exposure conditions of LIFE. The ultrastructural analysis of the algal cells provided an insight to cellular damages caused by long-term exposure and highlighted that desiccation-induced breakdown of cellular integrity is more pronounced under the more severe space vacuum than under Mars-analogue atmospheric conditions. In conclusion, desiccation-induced damages were identified as a major threat to the photobiont of X. elegans. Nonetheless, a fraction of the photobiont cells remained cultivable after all exposure conditions tested in LIFE.
在国际空间站(ISS)EXPOSE-E设施的 "地衣和真菌实验"(LIFE)中,Xanthoria elegans地衣暴露在太空和模拟火星环境中。559天的长期暴露测试了各种生物应对低地球轨道(LEO)或火星模拟环境的能力,如真空、火星模拟大气、快速温度循环、高达215 ± 16 mGy的宇宙辐射和累积剂量高达4.87 GJm(-2)的日照,包括高达0.314 GJm(-2)的紫外线辐照。在之前的一项研究中,X. elegans 通过光合作用活性以及暴露后藻类和真菌共生体的新陈代谢活性分别达到 50%-80% 和 60%-90% (Brandt 等,Int J Astrobiol 14(3):411-425,2015 年),证明其对这些条件具有相当强的抵抗力。本研究的两个目标是相辅相成的:首先,通过定性培养试验验证暴露后的高存活率。其次,通过透射电子显微镜(TEM)分析《生命之光》的太空和火星模拟暴露条件对细胞造成的损害。由于地衣的藻类共生体被认为是更易受影响的伙伴(de Vera 和 Ott,2010 年),因此分析重点放在了光生共生体上。研究表明,在 LIFE 的所有暴露条件下,分离出的光生菌体都在生长和增殖。对藻类细胞进行的超微结构分析有助于深入了解长期暴露对细胞造成的损害,并突出表明,与火星类似的大气条件相比,在更为严酷的太空真空条件下,干燥引起的细胞完整性破坏更为明显。总之,干燥引起的损伤被认为是对秀丽隐杆线虫光生体的主要威胁。尽管如此,在 LIFE 中测试的所有暴露条件下,仍有一部分光生菌体细胞可以继续培养。
{"title":"Characterisation of Growth and Ultrastructural Effects of the Xanthoria elegans Photobiont After 1.5 Years of Space Exposure on the International Space Station.","authors":"Annette Brandt, Eva Posthoff, Jean-Pierre de Vera, Silvano Onofri, Sieglinde Ott","doi":"10.1007/s11084-015-9470-1","DOIUrl":"10.1007/s11084-015-9470-1","url":null,"abstract":"<p><p>The lichen Xanthoria elegans has been exposed to space and simulated Mars-analogue environment in the Lichen and Fungi Experiment (LIFE) on the EXPOSE-E facility at the International Space Station (ISS). This long-term exposure of 559 days tested the ability of various organisms to cope with either low earth orbit (LEO) or Mars-analogue conditions, such as vacuum, Mars-analogue atmosphere, rapid temperature cycling, cosmic radiation of up to 215 ± 16 mGy, and insolation of accumulated doses up to 4.87 GJm(-2), including up to 0.314 GJm(-2) of UV irradiation. In a previous study, X. elegans demonstrated considerable resistance towards these conditions by means of photosynthetic activity as well as by post-exposure metabolic activity of 50-80% in the algal and 60-90% in the fungal symbiont (Brandt et al. Int J Astrobiol 14(3):411-425, 2015). The two objectives of the present study were complementary: First, to verify the high post-exposure viability by using a qualitative cultivation assay. Second, to characterise the cellular damages by transmission electron microscopy (TEM) which were caused by the space and Mars-analogue exposure conditions of LIFE. Since the algal symbiont of lichens is considered as the more susceptible partner (de Vera and Ott 2010), the analyses focused on the photobiont. The study demonstrated growth and proliferation of the isolated photobiont after all exposure conditions of LIFE. The ultrastructural analysis of the algal cells provided an insight to cellular damages caused by long-term exposure and highlighted that desiccation-induced breakdown of cellular integrity is more pronounced under the more severe space vacuum than under Mars-analogue atmospheric conditions. In conclusion, desiccation-induced damages were identified as a major threat to the photobiont of X. elegans. Nonetheless, a fraction of the photobiont cells remained cultivable after all exposure conditions tested in LIFE.</p>","PeriodicalId":55579,"journal":{"name":"Archiv Fur Dermatologie Und Syphilis","volume":"115 1","pages":"311-21"},"PeriodicalIF":2.0,"publicationDate":"2016-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11084-015-9470-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73126699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Verhandlungen der Berliner dermatologischen Vereinigung","authors":"","doi":"10.1007/BF02445558","DOIUrl":"https://doi.org/10.1007/BF02445558","url":null,"abstract":"","PeriodicalId":55579,"journal":{"name":"Archiv Fur Dermatologie Und Syphilis","volume":"24 1","pages":"893-911"},"PeriodicalIF":0.0,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02445558","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51923246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Verhandlungen des II. Internationalen Dermatologen-Congresses","authors":"","doi":"10.1007/BF02445563","DOIUrl":"https://doi.org/10.1007/BF02445563","url":null,"abstract":"","PeriodicalId":55579,"journal":{"name":"Archiv Fur Dermatologie Und Syphilis","volume":"24 1","pages":"985-1029"},"PeriodicalIF":0.0,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02445563","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51923749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Verhandlungen der Wiener dermatologischen Gesellschaft. 1892","authors":"","doi":"10.1007/BF02445557","DOIUrl":"https://doi.org/10.1007/BF02445557","url":null,"abstract":"","PeriodicalId":55579,"journal":{"name":"Archiv Fur Dermatologie Und Syphilis","volume":"24 1","pages":"835-892"},"PeriodicalIF":0.0,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02445557","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51923695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Beitrag zur Kenntniss der Sclerodermie","authors":"M. Wolters","doi":"10.1007/BF02445562","DOIUrl":"https://doi.org/10.1007/BF02445562","url":null,"abstract":"","PeriodicalId":55579,"journal":{"name":"Archiv Fur Dermatologie Und Syphilis","volume":"24 1","pages":"943-981"},"PeriodicalIF":0.0,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02445562","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51923310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Parasiten und parasitäre Affectionen","authors":"","doi":"10.1007/BF02445550","DOIUrl":"https://doi.org/10.1007/BF02445550","url":null,"abstract":"","PeriodicalId":55579,"journal":{"name":"Archiv Fur Dermatologie Und Syphilis","volume":"24 1","pages":"681"},"PeriodicalIF":0.0,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02445550","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51923477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Gonorrhoe und deren Complicationen","authors":"","doi":"10.1007/BF02445556","DOIUrl":"https://doi.org/10.1007/BF02445556","url":null,"abstract":"","PeriodicalId":55579,"journal":{"name":"Archiv Fur Dermatologie Und Syphilis","volume":"24 1","pages":"780-834"},"PeriodicalIF":0.0,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02445556","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51923663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}